Wednesday, April 6, 2016

UPDATE 2-Tax rules that killed Allergan-Pfizer deal may be hard to challenge

April 6 (Reuters) - U.S. tax rules are more difficult to sue over than other regulations that emanate from Washington, presenting a challenge to anyone considering a lawsuit over an Obama administration plan to discourage deals known as inversions, tax lawyers say.


Read more

No comments:

Post a Comment